SavedAdd your journal

Journals / Türk Onkoloji Dergisi / 2022 / Cilt: 37 - Sayı: 1

Chemotherapy Medicine-related Rare Toxic Reaction: Palmoplantar Erythrodysesthesia (Hand-foot Syndrome)

Zeynep Şengül EMEKSİZ
Serap ÖZMEN
Pages
100–101
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

EMEKSİZ, Z. Ş., ÖZMEN, S. (2022). Chemotherapy Medicine-related Rare Toxic Reaction: Palmoplantar Erythrodysesthesia (Hand-foot Syndrome). Türk Onkoloji Dergisi, Cilt: 37 - Sayı: 1, 100–101. https://ajindex.com/articles/639051

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Demircioğlu F, Oren H, Yilmaz S, Arslansoyu S, Eren S, Irken G, et al. Chemotherapy-induced acral ery thema in a pediatric patient with acute monoblastic leukemia. Pediatr Hematol Oncol 2008;25(3):211–5
  2. Nikolaou V, Syrigos K, Saif MW. Incidence and impli cations of chemotherapy related hand-foot syndrome. Expert Opin Drug Saf 2016;15(12):1625–33
  3. Jung S, Sehouli J, Patzelt A, Lademann J. Influence of mechanical stress on palmoplantar erythrodysesthesi a-a case report. Oncol Res Treat 2015;38(1–2):42–4
  4. Tunio MA, AlAsiri M, Durrani SK. Hand foot syn drome secondary to low dose docetaxel. Int J Health Sci (Qassim) 2015;9(3):335–7
  5. Chidharla, A, Talavera, F, Kasi, A. Chemotherapy acral erythema (palmar-plantar erythrodysesthesia, palmo plantar erythrodysesthesia, hand-foot syndrome). In: Stat Pearls. Treasure Island, FL: Stat Pearls Publishing; 2021.